Clik here to view.
Report: Congress on the cusp of freezing medical device tax
The U.S. Congress is reportedly on the cusp of agreeing on a 2-year freeze of the medical device tax and another tax enacted as part of Obamacare. The freeze is part of a 10-year, $500 billion tax...
View ArticleClik here to view.
NovoCure touts JAMA publication of Optune trial data
NovoCure (NSDQ:NVCR) said today data from the pivotal phase 3 trial of its Optune device, in combination with standard-of-care temozolomide, for treating newly diagnosed glioblastoma has been...
View ArticleClik here to view.
News from Europe: Trilogues, medical devices and IVD regulations carry on in...
By Ronald Boumans, Emergo Group The Dutch embassy in Brussels held a meeting to inform major stakeholders about the expected developments regarding negotiations about the new regulations for medical...
View ArticleClik here to view.
Autonomous robotic surgery on the horizon, says Ex-Google’s Parviz
Babak Parviz says he sold Google (NSDQ:GOOG) a vision of an autonomous surgical robot in 2010. His vision put the patient under the knife of a completely autonomous surgeon which would bring with it...
View ArticleClik here to view.
FDA launches precisionFDA to harness the power of scientific collaboration
By: Taha A. Kass-Hout, M.D., M.S. and Elaine Johanson Imagine a world where doctors have at their fingertips the information that allows them to individualize a diagnosis, treatment or even a cure for...
View ArticleClik here to view.
Funding pact includes pause for medical device tax
The $1.6 trillion deal struck last night on Capitol Hill to fund the government includes a provision that would put a 2-year pause on Obamacare’s medical device tax. The agreement, revealed by U.S....
View ArticleClik here to view.
Arch Therapeutics wins EU nod for AC5 hemostat trial
Arch Therapeutics (OTC:ARTH) said it won approval for a European safety-and-efficacy study of its AC5 surgical hemostat in bleeding wounds incurred during dermatology procedures. Framingham,...
View ArticleClik here to view.
Ex-GC sues Bio-Rad, alleging retaliation for blowing the whistle
The former general counsel for Bio-Rad (NYSE:BIO) accused the company and CEO Norman Schwartz of firing him in retaliation for blowing the whistle on alleged violations of the Foreign Corrupt Practices...
View ArticleClik here to view.
UC $250m tech innovation fund goes to NBA Kings owner Ranadivé
The University of California said it will put the funds from its $250 million tech fund into the care of entrepreneur Vivek Ranadivé, who will lead and build a team to invest in innovations coming out...
View ArticleClik here to view.
Can Sirtex turn cancer into a chronic disease?
Big things sometimes come in small packages. For Sirtex Medical, big things come in a really small package. The Australian medical device company’s flagship product – the SIR-sphere – is made up of 30...
View ArticleClik here to view.
LuxCath heart device sees 1st use in treating arrhythmia, AFIB
LuxCath said today its catheter-based ablation device was used in its 1st procedure to treat arrhythmia patients, including patients with atrial fibrillation. The surgeries were led by Mount Sinai...
View ArticleClik here to view.
Avenu Medical pulls in $6m for Ellipsys AV fistula device
Vascular access system maker Avenu Medical raised $6 million in a new round of debt financing, according to an SEC filing. Avenu Medical, founded in 2010, is developing and producing the Ellipsys...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for December 16, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Cardiovascular Systems wins extension in FCA case
Cardiovascular Systems (NSDQ:CSII) said yesterday it received an extension for responding to a False Claims Act brought against it in May 2014. The extension from the United States District Court for...
View ArticleClik here to view.
Viatom wins FDA nod for Checkme multi-diag ‘tricorder’ device
China-based Viatom Technologies won FDA 510(k) clearance for its Checkme Pro mult-diagnostic device, according to an FDA filing posted last week. The ‘tricorder’ style device performs pulse oximetry,...
View ArticleClik here to view.
Australian AtCor jumps on Japanese A&D distro deal
AtCor Medical Holdings said today it inked an exclusive, multi-year distribution deal with A&D Company to distribute the AtCor SphygmoCor Xcel device in Japan, sending stocks up as much as 10%. The...
View ArticleClik here to view.
ReVision touts visual acuity data from Raindrop trial
ReVision Optics today released data from a trial of its Raindrop implantable presbyopia-correcting corneal inlay, touting high rates of near visual acuity in treated patients versus untreated patients....
View ArticleClik here to view.
Abiomed buys Danvers, Mass HQ for $16.5m
Abiomed (NSDQ:ABMD) said last week it agreed to purchase its headquarters space in Danvers, Mass. from the Thibeault Nominee Trust for $16.5 million. The real estate at 18-22 Cherry Hill Drive consists...
View ArticleClik here to view.
Five predictions for medtech in 2016
by Brian Chapman The holidays are the perfect time for reflection. It’s time to think about the year and the accomplishments of the past, and especially to contemplate the future. It’s in this spirit...
View ArticleClik here to view.
Medical device tax delay would cost $3.4B
UPDATED Dec. 17, 2015, with news of House vote advancing omnibus bill, passing tax bill. The 2-year delay of the medical device tax would take $3.4 billion from the federal budget in 2016 and 2017,...
View Article